95383-36-1

Basic information

• Product Name: 2-BROMO-4-FLUOROBENZOYL CHLORIDE
• Synonyms: 2-BROMO-4-FLUOROBENZOYL CHLORIDE;2-(Chlorocarbonyl)-5-fluorobromobenzene;4-Fluoro-2-bromobenzoyl chloride;Benzoyl chloride, 2-broMo-4-fluoro-
• CAS NO: 95383-36-1
• Molecular Formula: C₇H₃BrClFO
• Molecular Weight: 237.45
• Product Categories: Fluorine series
• Mol File: 95383-36-1.mol
• Article Data: 29

Chemical Properties

• Boiling Point: 108-109/15mm
• Flash Point: 96℃
• Appearance: /
• Density: 1.742
• Vapor Pressure: 0.0495mmHg at 25°C
• Refractive Index: 1.561
• CAS DataBase Reference: 2-BROMO-4-FLUOROBENZOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4-FLUOROBENZOYL CHLORIDE(95383-36-1)
• EPA Substance Registry System: 2-BROMO-4-FLUOROBENZOYL CHLORIDE(95383-36-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 95383-36-1(Hazardous Substances Data)

Usage

General Description

2-BROMO-4-FLUOROBENZOYL CHLORIDE is a chemical compound with the molecular formula C7H3BrClFO. It is a benzoyl chloride derivative with the bromo and fluoro substitutions on the benzene ring. 2-BROMO-4-FLUOROBENZOYL CHLORIDE is commonly used in organic synthesis processes, particularly in the preparation of pharmaceutical intermediates and agrochemicals. It is a versatile reagent in organic chemistry and is used in the production of various compounds such as benzoyl fluorides, ketones, and esters. 2-BROMO-4-FLUOROBENZOYL CHLORIDE is a highly reactive and corrosive compound and should be handled with caution in a well-ventilated laboratory environment.

InChI:InChI=1/C7H3BrClFO/c8-6-3-4(10)1-2-5(6)7(9)11/h1-3H

Upstream product

• 79-37-8 oxalyl dichloride 
• 1006-41-3 2-bromo-4-fluorobenzoic acid 
• 1254073-58-9 4-[(3-chloro-4-fluoro-2-methylphenyl)carbonyl]-2-piperazinone 

Downstream Products

• 220603-06-5 [2-bromo-4-fluorophenyl]-(6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-6-yl)-methanone 
• 1017056-69-7 4-[(2-bromo-4-fluorophenyl)carbonyl]-2-piperazinone 
• 1273122-95-4 C₁₇H₁₂BrFN₂O₃ 
• 1309833-18-8 1-(2-bromo-4-fluorophenyl)-1,4-dihydro-5H-tetrazol-5-one 
• 1093869-25-0 C₃₂H₅₁FN₄O₅ 
• 1093868-46-2 3-((S)-1-cyclohexyl-3-(methylamino)propan-2-yl)-1-(2-((S)-6-fluoro-1-(4-methoxybutyl)-3-oxoisoindolin-1-yl)ethyl)-1-methylurea 
• 105398-60-5 5-fluoro-3-oxo-1,3-dihydroisobenzofuran-1-carbonitrile 
• 1503785-54-3 N,N-diethyl-4-fluoro-2-formylbenzamide 
• 1376129-52-0 2-benzyl-5-fluoro-2,3-dihydro-1H-inden-1-one 
• 935657-73-1 2-bromo-4-fluorobenzoic acid hydrazide 

Relevant articles and documents

PREPARATION METHOD FOR DEUTERATED MACROCYCLIC COMPOUND

Provided are a compound as represented by formula (D) and a preparation method therefor, where X2 is a halogen, Pg is selected from H and an amino protecting group, such as Cbz, Boc, Fmoc, Alloc, Teoc, methoxycarbonyl or ethoxycarbonyl. Also pr

Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer

As a recently discovered DNA repair enzyme, tyrosyl-DNA phosphodiesterase 1 (TDP1) removes topoisomerase IB (TOP1)-mediated DNA protein cross-links. Inhibiting TDP1 can potentiate the cytotoxicity of TOP1 inhibitors and overcome cancer cell resistance to

MOLLUGIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING THE SAME

The present invention relates to a pharmaceutical composition for treating inflammatory bowel diseases, comprising mollugin or a mollugin derivative applicable as a therapeutic agent for inflammatory bowel diseases, as an effective component. More specifi